TIM-3 was established as a negative regulator of T cell anti-tumor responses due to its association with an exhausted T cell state marked by the progressive loss of these cells’ ability to express IFN-γ, TNF-α and IL-2 [33,34,35]. The gene discussed is IL2; the disease is neoplasm.